Chemical Structure (Imiquimod 01)
Imiquimod Cream
Product Images NDC 51672-4145
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Imiquimod (NDC 51672-4145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Imiquimod 02)
This text represents the results of a clinical trial with Imiquimod Cream Vehicle. 209 people were enrolled, divided into two groups of 109 and 100 individuals. Some individuals completed the full 16 weeks of the treatment, while others withdrew early, and some did not achieve a clear outcome. Following the treatment, some individuals remained clear, while others experienced recurrences, and some were lost to follow-up.*
Principal Display Panel (24 Packet Carton)
This is a description of a topical medication (cream) called Imiquimod which is for dermatologic use only, not for ophthalmic use. It comes in single-use packets of 0.5 g each with a net weight of 0.25 grams per packet and six packets per box. Besides the active ingredient, Imiquimod 2.5 m, the cream contains a variety of inactive ingredients such as polysorbate, purified water, and alcohol. The cream should be stored at a temperature within the range of 47°F to 77°F to avoid freezing. It is important to keep the medication out of the reach of children. There is also a lot number and an expiry date provided, and a warning to consult the accompanying insert for dosage recommendations, directions for use, and other important prescribing information. The medication is manufactured by Taro Pharmaceutical Industries Ltd, Israel, and distributed by Taro Pharmaceuticals USA Inc, Hawthorne, NY 10532, USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
